CAR T-Cell Translation: The State of the Art

Monday, March 4, 2024, 11:00 AM - 12:00 PM, A Live Webinar

 CAR T-cell therapy has transcended the realm of promising research to become a game-changing FDA-approved treatment, offering newfound hope to hundreds of children and young adults facing once-incurable cancer.  Join us to discuss current advances in CAR T-cell therapy and the future of this treatment.

Topics include:

- Leveraging the translational CAR experience to enhance clinical outcomes
- Unraveling the mechanisms of antigen loss relapse after CD19 therapies in ALL
- GD2-CAR T-cell therapy for diffuse intrinsic pontine glioma and spinal cord diffuse midline glioma 
- Harnessing reverse translational research to optimize CAR T cells for children
- Tumor inflammation-associated neurotoxicity

Registration for all practitioners - free

To register for this activity, please click HERE. 


AMA PRA Category 1 Credits™ (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Describe how CAR T cell research is translated into the clinical environment
2. Determine whether CAR T-cell therapy might be a good fit for a patient
3. Review the current limitations of CAR T-cell therapy and what is being done to overcome them
4. Discuss new applications of CAR T-cell therapy in a growing group of cancers

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this live activity for a maximum of 1.00 ANCC contact hours.  

Cancellation Policy
Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Name: Emily Manche
     Title: CME Compliance Coordinator
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Monday, March 4, 2024